More Sustainability with Mechanochemistry

Research project will develop new environmentally friendly methods for manufacturing active pharmaceutical ingredients using mechanochemistry as a disruptive technology

29-Sep-2022 - Flour, coffee or spices: Many people know the principle of a mill from the kitchen. But special mills are also used for research purposes in the laboratories of the Max-Planck-Institut für Kohlenforschung. The scientists are convinced that mechanochemistry can make the chemical industry more ...

Phosphagenics appoints three non-executive directors to boost its commercial transformation

24-Aug-2010 - Phosphagenics Limited has appointed Mr Stuart James, Dr Sandra Webb and Mr Don Clarke as Non-Executive Directors to formulate and facilitate the implementation of strategies to commercialise the company’s research and development pipeline. All new Directors have senior commercial experience and ...

New products from forest biorefineries

11-May-2010 - VTT Technical Research Centre of Finland is the coordinator of a large EU project called AFORE, which is developing new technologies for the separation, fractionation and primary upgrading of wood-based polymers and valuable low molecular weight compounds to be used by the wood processing mills ...

Q Chip Ltd announces appointment of Tony Mills

05-Mar-2010 - Q Chip Ltd announced that it has appointed Dr Tony Mills to its Board of Directors. Tony brings a wealth of experience in commercialising technology in the biopharmaceutical sector and as Chief Commercial Officer, will be responsible for generating revenues from Q Chip’s proprietary technology, ...

Celtic Pharma Holdings commits funding to Cantab Biopharmaceuticals to drive the development of improved biological medicines

Jim Mills appointed as Cantab CEO

27-Jan-2010 - Celtic Pharma Holdings Advisors LLP announced it has made significant funding available to Cantab Biopharmaceuticals Limited for the development of improved biological medicines or ‘biosuperiors’, via the fund Celtic Pharma Holdings II LP (“CP2”). Cantab is a Cambridge, UK-based ...

BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility

23-Oct-2009 - BioStorage Technologies, Inc. will expand its European operations with the opening of a new 16,140 square foot (1,499 sq meters) full-service biorepository in Frankfurt, Germany. BioStorage Technologies’ expanded European operations is part of the company’s strategic growth plan to accommodate a ...

Second-generation Biofuels Heading Steadily towards Commercial Success, Asserts Frost & Sullivan

07-Oct-2009 - The utilisation of second-generation bio feedstock, such as agricultural residue, forest residue and black liquor, is currently limited to power generation in combined heat and power (CHP) plants or regeneration units. Second-generation bio feedstock has been extensively researched as a potential ...

Patheon completes York Mills facility sale

22-Apr-2008 - Patheon announced the completion of the sale of its York Mills facility located in Toronto, Canada for CDN$12.5 million (US$12.3 million) effective April 15, 2008. The agreement to sell the facility for a purchase price of CDN$12.5 million (US$12.3 million) was entered into on December 31, 2007 ...

Patheon Announces Executive Management Changes

21-Feb-2008 - Patheon Inc. announced changes in the roles of several of the Company's senior executives. Nick DiPietro will be assuming a new role as Executive Vice-President, Corporate Development and, accordingly, will relinquish his responsibilities as President and Chief Operating Officer of Patheon, ...

Boehringer Ingelheim Offers a Licence to Apotex to Export BI's patented product nevirapine to Developing Countries

27-Aug-2007 - Boehringer Ingelheim has offered the Canadian generic pharmaceutical manufacturer Apotex Inc. a royalty free, voluntary licence to manufacture and export products containing nevirapine to Rwanda as requested by Apotex. Boehringer Ingelheim has also offered to extend the license to other ...